查詢結果分析
來源資料
相關文獻
- Identification by Chemical Analysis of the Botanical Sources of Commercial Samples of Chinese Herbal Drugs
- 中藥摻加西藥成分檢驗研究之回顧與展望
- HPLC Assays of Naringin and Hesperidin in Chinese Herbs and Serum
- 利用毛細管電泳定量中藥製劑成分
- Determination of Xanthii Constituents by High-performance Liquid Chromatography and Capillary Electrophoresis
- 中藥材品質管制基準制定之研究(2-1)
- 中藥材品質管制基準制定之研究(2-2)
- 中藥材品質管制基準制定之研究(全程總報告)
- 中藥材品質管制基準制定之研究
- 中華中藥典之化學方法應用研究
頁籤選單縮合
題名 | Identification by Chemical Analysis of the Botanical Sources of Commercial Samples of Chinese Herbal Drugs=市售中藥材基原之化學鑑別 |
---|---|
作者 | 許順吉; | 書刊名 | 藥物食品分析 |
卷期 | 5:4 1997.12[民86.12] |
頁次 | 頁285-294 |
專輯 | 中藥專輯 |
分類號 | 414.32 |
關鍵詞 | 中藥材; 化學分析; 高效液相層析; 毛細管電泳; Chinese herbal drugs; Chemical analysis; High-performance liquid chromatography; Capillary electrophoresis; |
語文 | 英文(English) |
中文摘要 | 市售中藥材的基原可藉高效液相層析儀或毛細電泳分析比較其中某些特殊成分而 推定。麻黃素與偽麻黃素的比值可作為分辨不同麻黃品種的指標,該值在中麻黃遠小於1, 但其他品種均大於1。生物鹼的總含量可用於判斷市售黃柏樣品的來源,台灣黃柏與日本黃 柏均大於4O mg/g,但川黃柏與關黃柏則只有前述值的二分之一到三分之一。人參皂素,特 別是Rb ,含量在各種人參樣品中有很大差異,三七人參與美國人參遠高於高麗人參。同 樣方法可適用於黃連、芍藥、梔子、吳茱萸等藥材。 |
英文摘要 | The botanical sources of Chinese herbal drugs in a number of commercial samples could be inferred by comparing the contents of some characteristic constituents which were analyzed with high-performance liquid chromatography (HPLC) or capillary electrophoresis (CE). The ratio of ephedrine/pseudoephedrine could be used as a marker to differentiate Ephedra intermedia from other species; the former is unique in having a value far less than unity. The total amounts of alkaloids in Phellodendron wilsonii and P. amurense var. sachalinense were more than 40 mg/g, which were two th three times more than in P. amurense and P. chinense. The contents of ginsenosides in Panax notoginseng and P. quinquefolia were generally higher than in P. ginseng, especially in the case of Rb . |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。